• Careers

Webinars

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Interpreting Clinical Relevance of Immunogenicity Data Syngene

Learn from our client, Merck & Co., the relevance of PK and ADA data in a clinical setting, impact of neutralizing antibodies on PK and more.

Targeted Protein Degradation

Listen to what  our client, C4 Therapeutics has to say, about  the exciting opportunity that Targeted Protein Degradation represents to Biopharma companies around the world.

Advancing molecules from discovery to the clinic: A blueprint

Our client, Albireo, recently cleared phase-3 clinical trials for its drug Odevixibat. Learn from  Albireo’s experience, how to advance molecules from discovery to the clinic in the shortest possible time.

Building a successful ICH Stability CoE: Collaboratingn at scale

Syngene-Baxter R& D Centre is going strong even after 10 years. Undertand from our experts, the key elements of a great research partnership in ICH Stability Studies.